• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜静脉阻塞患者玻璃体内注射治疗后复发性黄斑水肿的光学相干断层扫描回顾性分析

Retrospective analyses of optical coherence tomography in recurrent macular edema following intravitreal therapy in patients with retinal vein occlusion.

作者信息

Holland Stephen M, Dodwell David G, Krimmel Darrel A, de Fiebre Christopher M

机构信息

Illinois Retina Center, Springfield, IL, 62704, USA.

Southern Illinois University School of Medicine, Springfield, IL, 62702, USA.

出版信息

BMC Ophthalmol. 2015 Sep 4;15:117. doi: 10.1186/s12886-015-0107-y.

DOI:10.1186/s12886-015-0107-y
PMID:26337708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4559365/
Abstract

BACKGROUND

Optical coherence tomography has focused mainly on central subfield thickness to quantify macular edema in central and branch retinal vein occlusion. We examined macular fields other than the central subfield to determine if they are possibly independent indicators of recurrent macular edema.

METHODS

Single center, retrospective, consecutive case study of patients with recurrent macular edema secondary to either central or branch retinal vein occlusion. Thickness estimates of serial domain optical coherence tomography macular fields were obtained at the time of recurrent macular edema and analyzed retrospectively. Changes were expressed as a percentage of previous baseline levels. Change in thickness at each retreatment episode as well as average changes in thickness were calculated for each macular field for each eye. Data were analyzed via analysis of variance and Fisher's post hoc analyses. The macular field which most frequently had the largest percent increase at the time of recurrence was also assessed using averages for each subject as well as for each retreatment episode. Individual episodes of recurrent macular edema were also examined to ascertain the frequency in which there was minimal foveal edema (<15 μm increase), but non-foveal edema was considered severe enough to warrant retreatment.

RESULTS

429 episodes of recurrent macular edema in 80 eyes were examined. In addition to the central subfield, the average mean change in thickness of the most affected quadrant (central vein occlusion) or hemisphere (branch vein occlusion) of the extrafoveal 3 mm band had the largest mean changes and also most frequently had the largest increases at the time of recurrent macular edema. In approximately 20 % of both central and branch occlusions, recurrent macular edema was detected in non-central macular fields in the absence of significant edema in the central subfield.

CONCLUSIONS

Analyses of non-central macular fields as well as the central subfield may be useful in the early detection and treatment of recurrent macular edema in retinal vein occlusion.

摘要

背景

光学相干断层扫描主要聚焦于中心子区域厚度,以量化视网膜中央静脉阻塞和分支静脉阻塞中的黄斑水肿。我们检查了中心子区域以外的黄斑区域,以确定它们是否可能是复发性黄斑水肿的独立指标。

方法

对视网膜中央静脉阻塞或分支静脉阻塞继发复发性黄斑水肿的患者进行单中心、回顾性、连续病例研究。在复发性黄斑水肿时获取系列域光学相干断层扫描黄斑区域的厚度估计值,并进行回顾性分析。变化以先前基线水平的百分比表示。计算每只眼睛每个黄斑区域每次再治疗时的厚度变化以及厚度的平均变化。通过方差分析和Fisher事后分析对数据进行分析。还使用每个受试者以及每次再治疗时的平均值评估复发时最常出现最大百分比增加的黄斑区域。还检查了复发性黄斑水肿的个体发作,以确定存在最小黄斑中心凹水肿(增加<15μm)但非黄斑中心凹水肿被认为严重到需要再治疗的频率。

结果

检查了80只眼中的429次复发性黄斑水肿发作。除中心子区域外,黄斑中心凹外3mm带中受影响最严重的象限(中央静脉阻塞)或半球(分支静脉阻塞)的平均厚度变化最大,并且在复发性黄斑水肿时也最常出现最大增加。在大约20%的中央和分支阻塞病例中,在中央子区域无明显水肿的情况下,在非中央黄斑区域检测到复发性黄斑水肿。

结论

分析非中央黄斑区域以及中心子区域可能有助于视网膜静脉阻塞中复发性黄斑水肿的早期检测和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22a2/4559365/43e78140cb29/12886_2015_107_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22a2/4559365/d6e2ff8b645a/12886_2015_107_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22a2/4559365/e86205b65528/12886_2015_107_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22a2/4559365/43e78140cb29/12886_2015_107_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22a2/4559365/d6e2ff8b645a/12886_2015_107_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22a2/4559365/e86205b65528/12886_2015_107_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22a2/4559365/43e78140cb29/12886_2015_107_Fig4_HTML.jpg

相似文献

1
Retrospective analyses of optical coherence tomography in recurrent macular edema following intravitreal therapy in patients with retinal vein occlusion.视网膜静脉阻塞患者玻璃体内注射治疗后复发性黄斑水肿的光学相干断层扫描回顾性分析
BMC Ophthalmol. 2015 Sep 4;15:117. doi: 10.1186/s12886-015-0107-y.
2
Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.前瞻性研究曲安奈德与贝伐单抗治疗视网膜中央静脉阻塞继发黄斑水肿。
Retina. 2011 May;31(5):838-45. doi: 10.1097/IAE.0b013e3181f4420d.
3
Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.玻璃体内注射曲安奈德治疗视网膜中央静脉阻塞相关的黄斑水肿。
Arch Ophthalmol. 2004 Aug;122(8):1131-6. doi: 10.1001/archopht.122.8.1131.
4
Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.玻璃体内雷珠单抗治疗视网膜静脉阻塞所致黄斑水肿:34 只眼的回顾性研究。
Acta Ophthalmol. 2012 Jun;90(4):357-61. doi: 10.1111/j.1755-3768.2010.01913.x. Epub 2010 Jun 29.
5
Area of peripheral retinal nonperfusion and treatment response in branch and central retinal vein occlusion.视网膜分支静脉阻塞和视网膜中央静脉阻塞中周边视网膜无灌注区及治疗反应
Retina. 2014 Sep;34(9):1736-42. doi: 10.1097/IAE.0000000000000148.
6
Rebound of macular edema after intravitreal bevacizumab therapy in eyes with macular edema secondary to branch retinal vein occlusion.继发于视网膜分支静脉阻塞的黄斑水肿患者行玻璃体内注射贝伐单抗治疗后黄斑水肿的反弹。
Retina. 2011 Jun;31(6):1075-82. doi: 10.1097/IAE.0b013e318206cf4b.
7
Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion.玻璃体内注射贝伐单抗治疗视网膜分支静脉阻塞所致黄斑水肿。
Retina. 2011 Oct;31(9):1856-62. doi: 10.1097/IAE.0b013e31820d59a5.
8
Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide.玻璃体腔注射曲安奈德治疗视网膜分支静脉阻塞继发的黄斑囊样水肿的早期治疗
Ophthalmic Surg Lasers Imaging. 2005 Jan-Feb;36(1):30-6.
9
Intravitreal bevacizumab and cytokine levels in major and macular branch retinal vein occlusion.玻璃体内贝伐单抗与大分支和黄斑分支视网膜静脉阻塞的细胞因子水平。
Ophthalmologica. 2011;225(3):150-4. doi: 10.1159/000322364. Epub 2010 Dec 9.
10
Highly reflective line in optical coherence tomography images of eyes with macular edema associated with branch retinal vein occlusion.视网膜分支静脉阻塞相关黄斑水肿患者眼部光学相干断层扫描图像中的高反射线。
Am J Ophthalmol. 2015 May;159(5):925-33.e1. doi: 10.1016/j.ajo.2015.01.033. Epub 2015 Jan 31.

引用本文的文献

1
The effect of center point shift on the measurement of macular thickness: a spectral domain-optical coherence tomography study.中心点偏移对黄斑厚度测量的影响:一项频域光学相干断层扫描研究
Graefes Arch Clin Exp Ophthalmol. 2017 Jun;255(6):1107-1113. doi: 10.1007/s00417-017-3615-z. Epub 2017 Mar 6.

本文引用的文献

1
VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study.VEGF Trap-Eye 治疗视网膜中央静脉阻塞继发黄斑水肿的 III 期 GALILEO 研究:6 个月结果。
Br J Ophthalmol. 2013 Mar;97(3):278-84. doi: 10.1136/bjophthalmol-2012-301504. Epub 2013 Jan 7.
2
General pathophysiology of macular edema.黄斑水肿的一般病理生理学
Eur J Ophthalmol. 2011;21 Suppl 6:S10-9. doi: 10.5301/EJO.2010.6050.
3
Extrafoveal changes following intravitreal bevacizumab injections for macular edema secondary to branch retinal vein occlusion: an mfERG and OCT study.
玻璃体腔注射贝伐单抗治疗视网膜分支静脉阻塞继发黄斑水肿后的黄斑外改变:一项多焦视网膜电图和光学相干断层扫描研究
Doc Ophthalmol. 2013 Apr;126(2):137-48. doi: 10.1007/s10633-012-9367-5. Epub 2012 Dec 20.
4
Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study.玻璃体内注射阿柏西普治疗视网膜中央静脉阻塞所致黄斑水肿:COPERNICUS 研究 3 期的 1 年结果。
Am J Ophthalmol. 2013 Mar;155(3):429-437.e7. doi: 10.1016/j.ajo.2012.09.026. Epub 2012 Dec 4.
5
Post-treatment change in the localization of recurrent or persistent macular edema secondary to branch retinal vein occlusion.治疗后分支视网膜静脉阻塞引起的复发性或持续性黄斑水肿定位的变化。
Ophthalmologica. 2012;228(1):1-6. doi: 10.1159/000334620. Epub 2012 May 31.
6
Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study.抗血管内皮生长因子 Trap-Eye 治疗视网膜中央静脉阻塞继发黄斑水肿的三期 COPERNICUS 研究:6 个月结果。
Ophthalmology. 2012 May;119(5):1024-32. doi: 10.1016/j.ophtha.2012.01.042. Epub 2012 Mar 21.
7
Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant.地塞米松眼内植入剂治疗视网膜静脉阻塞中黄斑水肿持续时间对临床结局的影响。
Ophthalmology. 2012 Jun;119(6):1190-8. doi: 10.1016/j.ophtha.2011.12.028. Epub 2012 Feb 22.
8
Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.地塞米松玻璃体内植入物治疗与分支或中央视网膜静脉阻塞相关的黄斑水肿患者的 12 个月研究结果。
Ophthalmology. 2011 Dec;118(12):2453-60. doi: 10.1016/j.ophtha.2011.05.014. Epub 2011 Jul 20.
9
Functional-morphologic correlates in patients with branch retinal vein occlusion and macular edema.伴有黄斑水肿的视网膜分支静脉阻塞患者的功能形态相关性。
Retina. 2011 Nov;31(10):2102-8. doi: 10.1097/IAE.0b013e318212e24d.
10
Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study.雷珠单抗治疗视网膜中央静脉阻塞继发黄斑水肿的持续获益:一项 III 期研究的 12 个月结果。
Ophthalmology. 2011 Oct;118(10):2041-9. doi: 10.1016/j.ophtha.2011.02.038. Epub 2011 Jun 29.